Stallion India Fluorochemicals Ltd
Stallion India Fluorochemicals Q4 FY26 earnings call: Revenue & Margins
Q4 FY26 earnings call: what management said on revenue, margins and capex.
Guidance rank: #9 of 71 in Chemicals & Petrochemicals
See the sector's top 10 — free with your mobile number.
Stallion India Fluorochemicals Ltd Q4 FY26 key numbers
- Revenue
- Current turnover is around INR 430 crores with a PAT of INR 40 crores.
As stated in Stallion India Fluorochemicals Ltd's Q4 FY26 earnings call transcript · published 24 May 2026. Reported figures, not investment advice.
The short version
Stallion India Fluorochemicals targets a revenue growth CAGR of 30-35% over the next three years. Target revenue by 2030: INR 3,000 crore with PAT of INR 500 crore.
From Stallion India Fluorochemicals Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Stallion India Fluorochemicals targets a revenue growth CAGR of 30-35% over the next three years.
- Current turnover is around INR 430 crores with a PAT of INR 40 crores.
- With the R-32 plant becoming fully operational, turnover is expected to cross INR 1100-1200 crores, with PAT around INR 180 crores.
- The HFO plant becoming operational will further boost revenues and profits.
- The company expects continuous expansion with one project stabilizing before starting the next.
- Long-term target by 2030 is INR 3000 crore revenue and INR 500 crore PAT.
- Demand for refrigerants and air-conditioning in India is expected to grow 10-15% annually for the next 10 years.
2 more points from Stallion India Fluorochemicals Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Stallion India Fluorochemicals Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Bhilwara HFO plant: Capex of around INR 200 crore (pure plant and machinery) as per government MOU; total capex likely around INR 400 crore. Commissioning targeted by October 2026.
- R-32 manufacturing facility: 10,000 metric ton capacity coming online; expected to start production by October, contributing significantly to revenue in FY27.
- Mumbattu facility expansion: Scaled up to a 12-tank facility to cover next 10 years; operational by August.
- Khalapur helium plant: Near completion, expected to start operations soon.
- HFO manufacturing plant: Planned post stabilization of Bhilwara plant, likely after mid-2027; capex range previously mentioned as INR 250 crore in current year and INR 500+ crore next year—conservative estimates.
2 more points from Stallion India Fluorochemicals Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Stallion India Fluorochemicals Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points from Stallion India Fluorochemicals Ltd's call on order book
Create a free account to keep reading this call
Stallion India Fluorochemicals Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹110 Cr, net profit ₹11 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Stallion India Fluorochemicals Ltd's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Indian Phosphate Ltd (Q4 FY26)
H2 FY26 Revenue (Consolidated):** ₹580.25 Cr, up from ₹451.59 Cr in H2 FY25 — a year-on-year increase of ₹128.66 Cr. Key investor presentation takeaways from In
- Paragon Fine (Q4 FY26)
Revenue for H2FY26:** Rs 68.88 Cr, up 7.41% YoY from Rs 64.13 Cr in H2FY25 (Page 22). Key investor presentation takeaways from Paragon Fine's Q4 FY26 investor p
- IVP Ltd (Q4 FY26)
Q4 FY26 revenue from operations: ₹164.44 crore . Key investor presentation takeaways from IVP's Q4 FY26 investor presentation — and how it ranks against sector
- Vishnu Chemicals Ltd (Q4 FY26)
Q4 FY26 Operating Revenues: ₹450.3 crore, up 14.7% YoY from ₹392.6 crore in Q4 FY25 (Page 5). Key investor presentation takeaways from Vishnu Chemicals Ltd's Q4
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Stallion India Fluorochemicals Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Stallion India Fluorochemicals Ltd Q4 FY26 results?
Stallion India Fluorochemicals targets a revenue growth CAGR of 30-35% over the next three years. Target revenue by 2030: INR 3,000 crore with PAT of INR 500 crore.
What is Stallion India Fluorochemicals Ltd share price analysis?
Stallion India Fluorochemicals Ltd currently shows a neutral. The stock trades at a P/E of 51.3 with a market cap of ₹2,668 Cr. Investors should review the full earnings analysis for detailed insights.
Is Stallion India Fluorochemicals Ltd planning capital expenditure?
Bhilwara HFO plant: Capex of around INR 200 crore (pure plant and machinery) as per government MOU; total capex likely around INR 400 crore.
Keep Stallion India Fluorochemicals Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.